Trials Annotator

Org. Study IDs: CCD-01534CA1-01
Secondary IDs: 2016-004547-36

Last trial update was posted on 2022-03-31

Poractant alfa

Hyaline Membrane Disease Respiratory Distress Syndrome Respiratory Distress Syndrome, Newborn Syndrome

Neonatal Respiratory Distress Syndrome

Change in the benefit-risk balance

N/A

Dani C, Talosi G, Piccinno A, Ginocchio VM, Balla G, Lavizzari A, Stranak Z, Gitto E, Martinelli S, Plavka R, Krolak-Olejnik B, Lista G, Spedicato F, Ciurlia G, Santoro D, Sweet D; CURONEB Study Group. A Randomized, Controlled Trial to Investigate the Efficacy of Nebulized Poractant Alfa in Premature Babies with Respiratory Distress Syndrome. J Pediatr. 2022 Jul;246:40-47.e5. doi: 10.1016/j.jpeds.2022.02.054. Epub 2022 Mar 5. [PMID: 35257740] [DOI: 10.1016/j.jpeds.2022.02.054]

No annotators decided on categories yet

#	Outdated	Intervention				Condition
#	Outdated	Name		Route	DrugBank ID	Condition